SharadAnantGhamandeMD
Obstetrics & Gynecology • Augusta, GAGynecologic Oncology
Associate Professor of Obstetrics & Gynecology, Medical College GA
Are you Dr. Ghamande?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1120 15th St
Georgia Regents Medical Associates
Augusta, GA 30912Phone+1 706-721-3993Fax+1 706-721-9777- Is this information wrong?
Summary
- Dr. Sharad Ghamande, MD is an obstetrician/gynecologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia and New York. He is affiliated with WellStar MCG Health, affiliated with Medical College of Georgia, Piedmont Augusta, and University Hospital Summerville.
Education & Training
Boston University Medical CenterResidency, Obstetrics and Gynecology, 1993 - 1997
Seth G.S. Medical CollegeClass of 1985
Certifications & Licensure
GA State Medical License 2000 - 2025
NY State Medical License 1997 - 2001- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENG...Mansoor R Mirza, Antonio González-Martín, Whitney S Graybill, David M O'Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M Guerra, Peter G Rose, Jean-François Baurain, Sh...> ;Future Oncology. 2024 Apr 1
- Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.Oaknin, A., Kasamatsu, Y., Gil-Martin, M., Grau-Bejar, J., Garcia-Duran, C., Sato, M., Siddiqui, A., Chaudhary, S., Vugmeyster, Y., Hasegawa, K., Ghamande, S.> ;Clinical Cancer Research. 2024 Mar 1
- Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.Jon A Hoin, Shantoria J Brown, Lynn M Durham, L Crain Garrot, Brian M Rivers, Cindy T Snyder, Sheryl Gordon Ann Gabram-Mendola, Bradley C Carthon, Sharad A Ghamande, A...> ;Frontiers in Health Services. 2024 Jan 1
- Join now to see all
Press Mentions
How Gaps in Health Insurance Coverage Haunt Vulnerable PatientsAugust 24th, 2021
Georgia Cancer Center Receives $6 Million Grant to Improve Access to Clinical TrialsSeptember 14th, 2019
Georgia Cancer Center CaRES Receives $6M for Clinical Trials for Minorities & Underserved PopulationsSeptember 14th, 2019- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Doctors Hospital of AugustaAugusta, Georgia
Piedmont AugustaAugusta, Georgia- University Hospital SummervilleAugusta, Georgia
WellStar MCG Health, affiliated with Medical College of GeorgiaAugusta, Georgia
